SG11201803023UA - Compositions comprising minerals and their use - Google Patents
Compositions comprising minerals and their useInfo
- Publication number
- SG11201803023UA SG11201803023UA SG11201803023UA SG11201803023UA SG11201803023UA SG 11201803023U A SG11201803023U A SG 11201803023UA SG 11201803023U A SG11201803023U A SG 11201803023UA SG 11201803023U A SG11201803023U A SG 11201803023UA SG 11201803023U A SG11201803023U A SG 11201803023UA
- Authority
- SG
- Singapore
- Prior art keywords
- minerals
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
- A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/34—Copper; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662315134P | 2016-03-30 | 2016-03-30 | |
US201662315152P | 2016-03-30 | 2016-03-30 | |
US201662315142P | 2016-03-30 | 2016-03-30 | |
US201662315163P | 2016-03-30 | 2016-03-30 | |
US201662315158P | 2016-03-30 | 2016-03-30 | |
US201662328112P | 2016-04-27 | 2016-04-27 | |
PCT/EP2016/080793 WO2017167419A1 (en) | 2016-03-30 | 2016-12-13 | Compositions comprising minerals and their use |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201803023UA true SG11201803023UA (en) | 2018-05-30 |
Family
ID=57614347
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201803023UA SG11201803023UA (en) | 2016-03-30 | 2016-12-13 | Compositions comprising minerals and their use |
SG11201806431RA SG11201806431RA (en) | 2016-03-30 | 2017-03-30 | Compositions comprising minerals and their use |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201806431RA SG11201806431RA (en) | 2016-03-30 | 2017-03-30 | Compositions comprising minerals and their use |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP3436032A1 (en) |
CN (2) | CN108367025A (en) |
BR (2) | BR112018011366A2 (en) |
CA (2) | CA3004044A1 (en) |
MX (2) | MX2018011678A (en) |
PH (3) | PH12018501129A1 (en) |
SG (2) | SG11201803023UA (en) |
WO (2) | WO2017167419A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW201924696A (en) | 2017-12-01 | 2019-07-01 | 瑞士商耐斯泰克公司 | Maternal supplement |
US20210338720A1 (en) * | 2018-08-27 | 2021-11-04 | Tinu Mary Samuel | Compositions and methods for the treatment of mastitis |
SG10201900604TA (en) * | 2019-01-23 | 2020-08-28 | Agency For Science Technology And Research Astarstar | Pre-natal beta-cryptoxanthin benefits children |
US20230040010A1 (en) * | 2020-01-16 | 2023-02-09 | Societe Des Produits Nestle S.A. | Compositions and methods for the treatment of mastitis |
WO2024038010A1 (en) | 2022-08-18 | 2024-02-22 | Société des Produits Nestlé S.A. | Kit to promote developmental myelination |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE84680T1 (en) | 1987-12-23 | 1993-02-15 | Nestle Sa | PROCESS FOR THE MANUFACTURE OF A WHEY PROTEIN HYDROLYSATE AND A HYPOALLERGENIC FOOD. |
EP0880902A1 (en) | 1997-05-27 | 1998-12-02 | Nestlé Produkte AG | Process for treating a raw whey material |
MXPA01010778A (en) | 1999-04-29 | 2003-08-20 | Nestle Sa | Composition for an infant formula having a low threonine content. |
WO2006099233A2 (en) * | 2005-03-10 | 2006-09-21 | Sciele Pharma, Inc. | Compositions and methods for the treatment of osteoporosis and inflammatory joint disease |
CN101902918A (en) * | 2007-10-19 | 2010-12-01 | 方塔拉合作集团有限公司 | Keep or increase the method for growth or cognitive development |
CN102946728B (en) * | 2010-03-12 | 2015-09-23 | 帝斯曼知识产权资产管理有限公司 | Maternal sialic acid is supplemented |
EP2454948A1 (en) | 2010-11-23 | 2012-05-23 | Nestec S.A. | Oligosaccharide mixture and food product comprising this mixture, especially infant formula |
CN102488011B (en) * | 2011-12-21 | 2013-07-31 | 澳优乳业(中国)有限公司 | Formula milk powder containing arachidonic acid for pregnant and parturient women and preparation method thereof |
-
2016
- 2016-12-13 WO PCT/EP2016/080793 patent/WO2017167419A1/en active Application Filing
- 2016-12-13 SG SG11201803023UA patent/SG11201803023UA/en unknown
- 2016-12-13 BR BR112018011366A patent/BR112018011366A2/en not_active IP Right Cessation
- 2016-12-13 CA CA3004044A patent/CA3004044A1/en not_active Abandoned
- 2016-12-13 CN CN201680072982.2A patent/CN108367025A/en active Pending
-
2017
- 2017-03-30 BR BR112018067730A patent/BR112018067730A2/en not_active Application Discontinuation
- 2017-03-30 SG SG11201806431RA patent/SG11201806431RA/en unknown
- 2017-03-30 WO PCT/EP2017/057572 patent/WO2017167896A1/en active Application Filing
- 2017-03-30 MX MX2018011678A patent/MX2018011678A/en unknown
- 2017-03-30 EP EP17715100.8A patent/EP3436032A1/en active Pending
- 2017-03-30 CN CN201780016220.5A patent/CN108778294A/en active Pending
- 2017-03-30 CA CA3015594A patent/CA3015594A1/en active Pending
-
2018
- 2018-05-28 PH PH12018501129A patent/PH12018501129A1/en unknown
- 2018-05-28 PH PH12018501128A patent/PH12018501128A1/en unknown
- 2018-08-28 PH PH12018501831A patent/PH12018501831A1/en unknown
- 2018-09-25 MX MX2022014684A patent/MX2022014684A/en unknown
Also Published As
Publication number | Publication date |
---|---|
BR112018067730A2 (en) | 2019-01-08 |
CN108778294A (en) | 2018-11-09 |
WO2017167896A1 (en) | 2017-10-05 |
BR112018011366A2 (en) | 2018-12-04 |
SG11201806431RA (en) | 2018-10-30 |
CA3015594A1 (en) | 2017-10-05 |
EP3436032A1 (en) | 2019-02-06 |
WO2017167419A1 (en) | 2017-10-05 |
PH12018501129A1 (en) | 2019-01-28 |
MX2018011678A (en) | 2019-01-10 |
PH12018501831A1 (en) | 2019-05-15 |
CA3004044A1 (en) | 2017-10-05 |
CN108367025A (en) | 2018-08-03 |
MX2022014684A (en) | 2023-01-11 |
PH12018501128A1 (en) | 2019-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1243741A1 (en) | Tnfrsf-binding agents and uses thereof | |
HUE057087T2 (en) | Tigit-binding agents and uses thereof | |
GB201411197D0 (en) | Composition and use thereof | |
ZA201803451B (en) | Probiotic compositions and uses thereof | |
PT3018183T (en) | Haloolefin-based composition and use thereof | |
IL250568B (en) | Anti-methanogenic compositions and uses thereof | |
IL264813B (en) | 2-oxo-imidazopyridines and their use | |
HK1257642A1 (en) | Cucurbituril compositions and their use | |
IL262045B (en) | Uv-protective compositions and their use | |
GB201502002D0 (en) | Uses and compositions | |
GB201608762D0 (en) | Compositions and uses thereof | |
SG11201803023UA (en) | Compositions comprising minerals and their use | |
SG11201803027PA (en) | Compositions comprising phospholipid and their use | |
HK1250915A1 (en) | Composition and uses thereof | |
PL3197273T3 (en) | Pesticide compositions and use thereof | |
GB201502026D0 (en) | Uses and compositions | |
GB201501991D0 (en) | Uses and compositions | |
IL251238A0 (en) | Mineral based compositions and use thereof | |
GB201705626D0 (en) | Compositions and methods | |
ZA201902130B (en) | Microparticle composition and use thereof | |
ZA201807665B (en) | Methods and compositions | |
GB201411196D0 (en) | Composition and use thereof | |
GB201715820D0 (en) | Compositions and methods | |
SG11201803025VA (en) | Compositions comprising vitamins and their use | |
GB201614897D0 (en) | Compositions and uses thereof |